Skip to main content
. Author manuscript; available in PMC: 2020 Sep 28.
Published in final edited form as: Ann Surg Oncol. 2015 Nov 5;23(3):959–967. doi: 10.1245/s10434-015-4952-y

TABLE 4.

Risk factors for disease-free survival in stage I

n 5-Year (%) Univariate Multivariate
HR (95 % CI) P value HR (95 % CI) P value
Age (years) 0.001
  <50 280 96.2 1 1
  50–59 337 92.1 2.05 (0.85–4.94) 1.98 (0.81–4.82) 0.13
  ≥60 334 85.6 3.97 (1.73–9.09) 2.34 (0.97–5.63) 0.057
Ethnicity 0.019
  Caucasian 135 83.6 1 1
  African American 24 100 NA NA 0.97
  Hispanic 423 93.8 0.35 (0.16–0.75) 0.49 (0.22–1.14) 0.098
  Asian 369 90.6 0.72 (0.35–1.46) 0.71 (0.33–1.54) 0.39
Histology <0.001
  Endometrioid 837 93.6 1 1
  Serous 36 64.2 4.39 (1.84–10.5) 0.73 (0.24–2.19) 0.58
  Clear cell 14 62.2 9.14 (3.23–25.8) 1.99 (0.60–6.59) 0.26
  Other 64 80.0 3.70 (1.77–7.73) 1.82 (0.79–4.16) 0.16
Grade <0.001
  Low grade 815 94.4 1 1
  High grade 134 72.3 6.00 (3.48–10.3) 4.19 (2.08–8.46) <0.001
EC-AIA <0.001
  No 921 92.0 1 1
  Yes 30 68.9 5.21 (2.22–12.2) 3.90 (1.46–10.4) 0.007

The log-rank test for univariate analysis and the Cox proportional hazard regression test for multivariate analysis. Significant P values are in bold type. Chi square value: 87.5 (P < 0.001)

HR Hazard ratio, CI confidence interval, NA not available, EC-AIA endometrial cancer arising in adenomyosis